Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, China; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China.
Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, China; Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, China.
Phytomedicine. 2024 Dec;135:156122. doi: 10.1016/j.phymed.2024.156122. Epub 2024 Oct 5.
The gut microbiota is believed to influence atherosclerosis (AS), and Aucubin (Au), a natural compound found in the traditional Chinese medicine Eucommia ulmoides Oliver, is being explored as a potential treatment for cardiovascular disease. Yet, the specific impact of Au on AS through the gut microbiota remains unclear.
This study aimed to highlight the potential of Au in improving AS by influencing gut microbiota and investigating its potential mechanisms by which it and its metabolites of gut microbiota regulate lipid metabolism, inflammation and endothelial dysfunction.
The impact of Au on AS in ApoE mice was examined, followed by a fecal microbiota transplantation experiment to confirm the influence of Au on AS through gut microbiota. Subsequent analysis of fecal and serum samples using 16S rRNA gene sequencing and metabolomics revealed distinct features of gut microbiota and metabolites. Identified metabolites were then utilized in vivo experiments to investigate underlying mechanisms.
Au treatment effectively reduced dietary-induced dyslipidemia and endothelial dysfunction in a dose-dependent manner in atherosclerotic mice. It also improved vascular plaque accumulation and inflammation, increased aortic valve fibrous cap thickness, and decreased necrotic core and collagen fiber area. Subsequently, we observed a substantial increase in indole-3-acrylic acid (IAA), a microbe-derived metabolite, in cecal contents and serum, along with a significant rise in Lactobacillus abundance responsible for IAA production. Our findings demonstrated that IAA played a crucial role in alleviating AS. Furthermore, we discovered that IAA activated the Aryl hydrocarbon receptor (AhR) and suppressed the TGF-β/Smad pathway, potentially ameliorating endothelial-mesenchymal transitions in atherosclerotic mice.
These findings suggested that Au's anti-atherosclerotic effects were primarily due to elevated Lactobacillus-derived IAA, thereby potentially contributing to alleviating AS.
肠道微生物群被认为会影响动脉粥样硬化(AS),而从传统中药杜仲中发现的天然化合物梓醇(Au)正被探索作为心血管疾病的潜在治疗方法。然而,Au 通过肠道微生物群对 AS 的具体影响尚不清楚。
本研究旨在通过影响肠道微生物群来强调 Au 改善 AS 的潜力,并研究其通过肠道微生物群调节脂质代谢、炎症和内皮功能障碍的潜在机制。
研究了 Au 对 ApoE 小鼠 AS 的影响,随后进行了粪便微生物群移植实验,以确认 Au 通过肠道微生物群对 AS 的影响。随后使用 16S rRNA 基因测序和代谢组学分析粪便和血清样本,揭示了肠道微生物群和代谢物的独特特征。鉴定出的代谢物随后在体内实验中用于研究潜在机制。
Au 治疗可有效降低饮食诱导的高脂血症和内皮功能障碍,呈剂量依赖性。它还改善了血管斑块积聚和炎症,增加了主动脉瓣纤维帽厚度,减少了坏死核心和胶原纤维面积。随后,我们观察到肠道内容物和血清中吲哚-3-丙烯酸(IAA)的含量显著增加,这是一种微生物衍生的代谢物,同时负责 IAA 产生的乳杆菌丰度也显著增加。我们的研究结果表明,IAA 在缓解 AS 方面发挥了关键作用。此外,我们发现 IAA 激活了芳香烃受体(AhR)并抑制了 TGF-β/Smad 通路,可能改善了动脉粥样硬化小鼠的内皮间充质转化。
这些发现表明,Au 的抗动脉粥样硬化作用主要归因于丰度增加的乳杆菌衍生的 IAA,从而可能有助于缓解 AS。